Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
May 24, 2017
The article explains that FDNA, the creator of a cutting-edge facial recognition app, has partnered with leading genetic testing companies to enhance genetic diagnostics and personalized medicine. This innovative decision support tool uses advanced algorithms to analyze facial features, aiding in the identification of genetic syndromes. By integrating this technology, genetic testing firms aim to improve diagnostic accuracy and efficiency. This collaboration highlights the growing role of digital health innovations in medical diagnostics. FDNA’s face recognition app exemplifies how traditional genetic testing can leverage AI and machine learning, setting a new standard in the landscape of digital health solutions.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…